Bruce Poliquin sold Ganaden Biotech, Co [PS] (--)
Bruce Poliquin (R-ME), a U.S. Representative, has disclosed 1 trade in Ganaden Biotech, Co [PS] (--) since 2017, a single sale, worth an estimated $3.0M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Bruce Poliquin sold $1,000,001 - $5,000,000 of Ganaden Biotech, Co [PS] (--) on September 1, 2017. Since that trade, -- is up +0.00% against the S&P 500 up +247.89%, an outperformance of -247.89%.
Data updated
Bruce Poliquin's -- trades vs the price
-- is up +0.00% since Bruce Poliquin sold on September 1, 2017, versus +247.89% for the S&P 500.
Performance since this trade
All Bruce Poliquin -- trades
Bruce Poliquin & -- trading FAQ
Is it legal for Bruce Poliquin to trade Ganaden Biotech, Co [PS] (--) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Ganaden Biotech, Co [PS] (--), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Bruce Poliquin sell --?
Bruce Poliquin disclosed a sale of $1,000,001 - $5,000,000 of Ganaden Biotech, Co [PS] (--) on September 1, 2017, according to public STOCK Act filings.
How has -- performed since Bruce Poliquin's trade?
Since Bruce Poliquin sold -- on September 1, 2017, the stock is up +0.00%, versus +247.89% for the S&P 500 over the same period, an outperformance of -247.89%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional -- trades?
BullishWhales tracks every disclosed congressional trade in Ganaden Biotech, Co [PS] (--) on the Ganaden Biotech, Co [PS] congressional trading page, which aggregates filings across all members of Congress.
Bruce Poliquin's -- tradesAll congressional filings for Ganaden Biotech, Co [PS]Bruce Poliquin's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.